| Assessment Status | Rapid Review Complete |
| HTA ID | - |
| Drug | Insulin aspart |
| Brand | Fiasp® |
| Indication | For the treatment of diabetes mellitus in adults. |
| Assessment Process | |
| Rapid review commissioned | 17/05/2017 |
| Rapid review completed | 14/06/2017 |
| Rapid review outcome | Full Pharmacoeconomic Assessment Not Recommended |